“Time Is Brain”: Indian Stroke Association Calls For National Stroke Green Corridors And 112 Integration

IMT News Desk
IMT News Desk
· 4 min read
“Time Is Brain”: Indian Stroke Association Calls For National Stroke Green Corridors And 112 Integration

The Indian Stroke Association has proposed a comprehensive national framework to improve stroke outcomes by integrating stroke response with the National Emergency Number 112, enabling GPS-based ambulance routing, mapping certified stroke centers and expanding green corridors beyond organ transplants to ensure faster, life-saving care for neurological emergencies

In the wake of the recent IPL head injury incident, where a green corridor enabled rapid hospital transport, the Indian Stroke Association (ISA) has strongly advocated for a nationwide system of green corridors for stroke, head injury and trauma patients, emphasizing that timely intervention is critical to saving brain function and lives.

Dr. Vikram Huded, President, Indian Stroke Association (ISA), highlighted the urgent need for system-level reforms in emergency stroke care across India. Strengthening emergency response systems is now more important than ever, as delays in reaching the right hospital continue to be one of the biggest barriers to effective stroke care across the country.

“Every minute of delay in stroke leads to irreversible loss of brain cells. Unlike other organs, the brain cannot be transplanted. The rapid response seen during the IPL incident demonstrates what is possible when systems are aligned. We must extend this same level of urgency to every citizen suffering from stroke or head injury. The Indian Stroke Association has proposed a comprehensive national framework to improve stroke outcomes. This includes integration with the National Emergency Number 112, embedding stroke identification protocols within the emergency response system, and ensuring immediate activation of stroke pathways upon receiving a call. We also recommend GPS-enabled ambulance routing and smart systems that transport patients to the nearest certified stroke-ready hospital, with a focus on reaching the right hospital, not just the closest one. In addition, there is a need for national mapping of stroke centers and government-supported integration of these centers into digital platforms for real-time accessibility by emergency services. Expanding green corridors beyond organ transplants to include neurological emergencies such as acute stroke, severe head injury, and trauma can further help save critical time and lives,” said Dr. Vikram Huded, President, Indian Stroke Association (ISA). 

Dr. Huded further added, “India has the expertise and infrastructure to transform stroke care. What we need now is system integration and policy support. With the right emergency response framework, we can significantly reduce disability and save lives.”

“Stroke care in India is at a defining moment, where progress in medical science must be matched by faster and more efficient access to care. While we have advanced technology and skilled specialists, many patients still miss the critical treatment window due to delays in recognition and transport. Improving public awareness about early symptoms and strengthening emergency response systems can make a significant difference in outcomes. Timely intervention not only saves lives but also reduces long-term disability and improves quality of life. Communities, healthcare providers, and emergency services must work together in a coordinated manner. Every minute counts, and acting quickly can truly make the difference between recovery and lifelong impact,” said Dr. Arvind Sharma, Secretary, Indian Stroke Association (ISA).

The Indian Stroke Association urges policymakers, healthcare leaders, and emergency response authorities to collaborate in implementing these recommendations and ensuring that “No brain is lost due to delay.” ISA has also launched the ‘Save the Brain’ initiative, a nationwide campaign aimed at increasing public awareness that stroke is preventable and treatable, promoting early recognition using BEFAST symptoms – Balance difficulty, Eye vision changes, Facial drooping, Arm weakness, Speech difficulty, and Time to act, encouraging routine screening of risk factors, especially hypertension, and training physicians and healthcare systems across India. The year 2027 marks 100 years of cerebral angiography, pioneered by Egas Moniz. ISA plans to leverage this milestone to conduct nationwide CMEs, strengthen stroke systems of care, and build large-scale public awareness.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk